Skip to main content
. 2023 Sep 27;15:191–198. doi: 10.2147/ORR.S408718

Figure 2.

Figure 2

Worldwide distribution of the regions in which studies have been conducted to evaluate the risk of osteosarcoma among individuals receiving TPTD.